ArticleThe Journal of infectious diseases2024

Effectiveness of BNT162b2 BA.4/5 Bivalent mRNA Vaccine Against Symptomatic COVID-19 Among Immunocompetent Individuals Testing at a Large US Retail Pharmacy.

Abby E Rudolph et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.